Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI
Volume: 31, Issue: 11, Pages: 2725 - 2735
Published: Sep 22, 2020
Abstract
AKI commonly occurs in patients with coronavirus disease 2019 (COVID-19). Its pathogenesis is poorly understood. The urokinase receptor system is a key regulator of the intersection between inflammation, immunity, and coagulation, and soluble urokinase plasminogen activator receptor (suPAR) has been identified as an immunologic risk factor for AKI. Whether suPAR is associated with COVID-19-related AKI is unknown.In a multinational observational...
Paper Details
Title
Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI
Published Date
Sep 22, 2020
Volume
31
Issue
11
Pages
2725 - 2735
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History